# Uniq Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uniq-health

- Industry: Healthcare IT
- Headquarters: Cambridge, UK
- Website: www.tuune.com
- Total disclosed funding: $3M
- Latest round: Seed (Dec 14, 2020)
- Investors on record: 1

## About

Uniq Health Limited offers personalized hormonal health solutions, enhancing patient care through advanced algorithms. Their focus on hormonal and reproductive health aims to improve outcomes for patients seeking tailored treatment plans.Founded in 2018 and based in Cambridge, UK, Uniq Health Limited specializes in hormonal health solutions. The company has undertaken one significant deal, raising USD 3.00 mn in Seed funding on December 14, 2020, led by Octopus Investments. The CEO and founder, Shardi Nahavandi, has a background in health technology, contributing to the company’s innovative approach in the sector.TUUNE specializes in personalized hormonal health solutions through its proprietary algorithm, designed to enhance patient outcomes in hormonal and reproductive health. The core product offering includes a comprehensive assessment tool that captures detailed health information from patients prior to their appointments. This tool analyzes various factors such as health history, symptoms, medication eligibility, and relevant medications, synthesizing insights from thousands of scientific and clinical sources. The algorithm generates tailored, evidence-based treatment plans that cater to each patient's unique needs, facilitating informed discussions between healthcare providers and patients. TUUNE primarily serves healthcare professionals, including OBGYNs and nurse practitioners, across various geographical markets, focusing on regions where women’s health services are emphasized, such as urban and suburban areas in the United States.The revenue model for TUUNE is built around service subscriptions for healthcare practitioners who utilize the platform to improve patient interactions and outcomes. Clients, including clinics and individual practitioners, access TUUNE's algorithm through subscription-based plans, which may offer tiered pricing aligned with the number of users or volume of patient assessments. Additionally, TUUNE's services enhance the efficiency of appointments, potentially leading to higher patient throughput and increased satisfaction rates, which in turn may foster long-term partnerships with healthcare providers. The revenue stream is further bolstered by the value derived from improved patient outcomes and operational efficiencies, offering a compelling proposition for healthcare providers looking to optimize their practices.In December 2020, Uniq Health Limited raised USD 3.00 mn in Seed funding, which will be utilized to support its launch in the US market. The company aims to expand its reach by introducing new products tailored to meet the needs of healthcare providers, though specific product launches are yet to be announced. Plans for geographic expansion are focused on increasing access to its services in urban and suburban areas across the United States, targeting a timeline that aligns with the growth opportunities presented by their recent funding.

## Funding rounds

- Seed, Dec 14, 2020, $3M — Octopus Investments

## Investors

- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Seed